Estimation of Blood-Borne Virus Infections in Beta Thalassemia Major Patients
DOI:
https://doi.org/10.21070/medicra.v8i2.1815Keywords:
Thalassemia, Hepatitis C Virus, Hepatitis B VirusAbstract
Thalassemia is a heterogeneous inherited anemia caused by mutations affecting globin-chain synthesis in hemoglobin, leading to ineffective erythropoiesis and hemolytic anemia. Patients commonly require lifelong blood transfusions, which increase the risk of transfusion-transmitted infections such as hepatitis B and C, potentially worsening health outcomes. This cross-sectional study aimed to determine the frequency and distribution of hepatitis viruses among thalassemia patients and their association with thalassemia type, transfusion history, splenic status, and sociodemographic factors. The study was conducted at the Hematology Center of Al-Diwaniyah Health Department from February to August 2024 and included 328 patients. Blood samples (3–5 mL) were tested for hepatitis viruses using ELISA, and data were analyzed with SPSS 20. Results showed HCV positivity in 3/328 (0.9%) patients and HBsAg positivity in 1/328 (0.3%), with equal distribution between sexes and higher prevalence in urban areas and the 16–25-year age group. All infected patients received twice-monthly transfusions, most had low educational and income levels, and only one had undergone splenectomy. The study confirms the presence of HBV and HCV infections in multi-transfused thalassemia patients, with infection risk increasing with age and number of transfusions, particularly for HCV.
References
Abd Hussein, T., Tawfeeq, N. A., Hussein, H. G., Mohammed, H. H., Mohammed, W. J., & Ibraheem, D. S. (2024). Distribution of blood groups with β-thalassemia mutations in Iraqi patients. ISAR J Med Pharm Sci, 2 (9), 38-44. https://isarpublisher.com/journal/isarjmps
Ahmed, S., Ayub, M., Naeem, M., Nazir, F. H., Hussain, A., Ghilzai, D., Magnius, L. O., Sajjad, A., & Norder, H. (2021). Thalassemia Patients from Baluchistan in Pakistan Are Infected with Multiple Hepatitis B or C Virus Strains. The American Journal of Tropical Medicine and Hygiene, 104(4), 1569-1576. Retrieved from https://doi.org/10.4269/ajtmh.20-0740
Ali, Z. H. (2018). Prevalence and risk factors for hepatitis C virus in Beta thalassemic patients attending blood diseases center in Ibn-AL-Baladi Hospital, Baghdad. Al-Kindy College Medical Journal, 14(1), 42-49
Altaf, W., & Hussain, M. (2025). Frequency of Hepatitis B Virus and Hepatitis C Virus Infection in Beta Thalassemia Major Children in Tertiary Care Hospital. Indus Journal of Bioscience Research, 3(1), 444-448. Doi: 10.70749/ijbr.v3i1.490
Al Badry, BJ. (2025). Epidemiology, mode of transmission and risk factors of hepatitis C virus (HCV) infections in Thi-Qar province, Iraq. Int J Advan Res, 3(10), 1025-1032
Al-Greti, S. H. H. (2013). Prevalence of hepatitis C virus in beta-thalassemia major patients at Karbala governorate. Journal of Babylon University/Pure and applied Sciences, 21(8), 2801-5. Retrieved from: https://www.researchgate.net/publication/336100071_prevalence_of_hepatitis_c_virus_in_Beta-thalasemia_major_patients_at_Karbala_governorate
Al-Sharifi, Liqaa Mohammed., Murtadha, J., Shahad, A., Mohammed, Y., Sura, J., Waleed, Z., Raheeq, M., Sura, A., Ehab, H., Shahad, M., Abbas, Q. (2019). Prevalence of Hepatitis B and C in Thalassemic Patients and its Relation with Type of Thalassemia, Frequency of Blood Transfusion, and Spleen Status. Medical Journal of Babylon, 16(2), 108-111. doi: 10.4103/MJBL.MJBL_6_19
Al-Zuheiry, M. S. (2016). The Prevalence and the Quantification of Hepatitis C Virus among Thalassemia Patients using ELISA and PCR in Diyala Province. Diyala Journal of Medicine, 10(2), 63-69.
Ansari SH, Shamsi TS, Khan MT, Perveen K, Farzana T, Erum S, Ansari I. (2012). Seropositivity of Hepatitis C, Hepatitis B and HIV in chronically transfused ββ-thalassaemia major patients. J Coll Physicians Surg Pak. 22(9):610-1. Retrieved from: https:pubmed.ncbi.nlm.nih.gov/22980623
Anticona Huaynate, C. F., Pajuelo Travezaño, M. J., Correa, M., Mayta Malpartida, H., Oberhelman, R., Murphy, L. L., & Paz-Soldan, V. A. (2015). Diagnostics barriers and innovations in rural areas: insights from junior medical doctors on the frontlines of rural care in Peru. BMC health services research, 15, 454. Doi: 10.1186/s12913-015-1114-7
Arwa, A. A. and Abdulrhem T. Y. A. (2019). Prevalence of Hepatitis C Virus in Thalassemia and Hemoglobinopathies in Duhok City/Iraq. Research Journal of Medical Sciences, 13: 11-15
Aziz, A., Sayed, S., Ismail, D., & Mohamed, Z. (2022). Hematological Parameters in Beta Thalassemia Major Children. Minia Journal of Medical Research, 33(2), 167-170. doi: 10.21608/mjmr.2022.255684
Cropley A, and Weltman, M. (2017). The use of immunosuppression in autoimmune hepatitis: A current literature review. Clin mol hepatol, 23(1):22-26. Retrieved from e-cmh.org/journal/view.php?doi=10.3350/cmh.2016.0089
Farmakis, D., Porter, J., Taher, A., Domenica Cappellini, M., Angastiniotis, M., & Eleftheriou, A. (2022). 2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia. HemaSphere, 6(8), e732. Doi: 10.1097/HS9.0000000000000732
Hama, S.A., Sawa, M.I. (2017). Prevalence of hepatitis B, C, and D among thalassemia patients in sulaimani governorate. Kurdistan Journal of Applied Research, 2(2), 137-42. Doi: 10.24017/science.2017.2.20
Hassan, A., Al-Omary, T., Abbas, S., & Al-hraishawi, H. (2024). Prevalence rate of Hepatitis C virus among B- Thalassemia major patients in Misan, Iraq. Journal of Bioscience and Applied Research, 10(6), 15-21. doi: 10.21608/jbaar.2024.394782
Herbert L, Muncie JR, Campbell JS. (2009). Alpha and beta thalassemia. Am Fam Physician. 80(4), 339-344. Retrieved from https://www.aafp.org/pubs/afp/issues/2009/0815/p339.html
Jang TY, Lin PC, Huang CI, Liao YM, Yeh ML, et al. (2017) Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients. PLOS ONE, 12(6), 1-11, e0178883. Doi: 10.1371/journal.pone.0178883
Kattamis, A., Forni, G. L., Aydinok, Y., & Viprakasit, V. (2020). Changing patterns in the epidemiology of β-thalassemia. European journal of haematology, 105(6), 692–703. Doi: doi.org/10.1111/ejh.13512
Khalil S, Khan HS, Akhtar P. (2016). Status of hepatitis B and C in beta thalassemia major patients. Journal of Islamabad Medical & Dental College (JIMDC). 5(2):71-3. Retrieved from https://share.google/XMIWU4eyORtABLCKe
Langer AL. (2000). Beta-Thalassemia. 2000 Sep 28 [Updated 2024 Feb 8]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1426/
Mandal, T. K., Sarkar, S., Haldar, P., Mondal, S., Chatterjee, S. S., Paul, P., Ray, R., Ghosh, R. R., Saha, S., & Dan, U. (2024). Prevalence of HIV, hepatitis B and hepatitis C infections among patients with thalassemia attending a tertiary care (rural) hospital. Journal of family medicine and primary care, 13(5), 1780–1786. Doi: 10.4103/jfmpc.jfmpc_1751_23
Muhsin, M. A., & Abdul-Husin, I. F. (2013). Seroprevalence of hepatitis B and C among thalassemic, haemophilic patients in Babylon Governorate-Iraq. Medical Journal of Babylon, 10(2), 445-454. Retrieved from https://share.google/yoSz7yof5DV1tXD6o
Mukherjee, K., Bhattacharjee, D., & Chakraborti, G. (2017). Prevalence of hepatitis B and hepatitis C virus infection in repeatedly transfused thalassemics in a tertiary care hospital in eastern India. Int J Res Med Sci, 5(10), 4558-4562. Doi: 10.18203/2320-6012.ijrms20174596
Muslim, T. M. (2014). Epidemiologic Study of Hepatitis B and C Virus Among Thalassemia Patient in Wassit Governorate/Iraq.Al-Taqani, 27(2), 1-6. Retrieved from https://share.google/scTe7H82PNFt7Dj0R
Najim OA, Hassan MK. (2018). Prevalence of hepatitis C virus seropositivity among multitransfused patients with hereditary anemias in Basra, Iraq. Iraqi Journal of Hematology, 7(1), 39-44. Doi: 10.4103/ijh.ijh_41_17
Okunrintemi, V., Khera, R., Spatz, E. S., Salami, J. A., Valero-Elizondo, J., Warraich, H. J., Virani, S. S., Blankstein, R., Blaha, M. J., Pawlik, T. M., Dharmarajan, K., Krumholz, H. M., & Nasir, K. (2019). Association of Income Disparities with Patient-Reported Healthcare Experience. Journal of general internal medicine, 34(6), 884–892. Doi: 10.1007/s11606-019-04848-4
Origa, R. (2023). Hepatitis C and Thalassemia: A Story with (Almost) a Happy Ending. Pathogens, 12(5), 683. Doi: 10.3390/pathogens12050683.
Othman RA, Abbas YA. (2020)Prevalence of Hepatitis B and C in Thi-Qar Province-Iraq from 2015-2019. European Journal of Molecular & Clinical Medicine,7(2),43-8. Retrieved from https://share.google/cP0d2DkP1hE8AaX9I
Reyes, R., Ahn, R., Thurber, K., & Burke, T. F. (2012). Urbanization and Infectious Diseases: General Principles, Historical Perspectives, and Contemporary Challenges. Challenges in Infectious Diseases, 123–146. Doi: 10.1007/978-1-4614-4496-1_4
Raghupathi, V., Raghupathi, W. (2020). The influence of education on health: an empirical assessment of OECD countries for the period 1995–2015. Arch Public Health 78, 20. Doi: 10.1186/s13690-020-00402-5
Raham TF, Wahed SS, Alhaddad HN. (2011). Prevalence of Hepatitis C among patients with βthalasemia in Diyala-Iraq. Journal of Techniques. 24(4), 1-8. Retrieved from https://share.google/IU5swjimRvVGY7Dmr
Rao, E., Chandraker, S. K., Singh, M. M., & Kumar, R. (2024). Global distribution of β-thalassemia mutations: An update. Gene, 896, 148022. Doi: 10.1016/j.gene.2023.148022
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mohammed Abdulkadhim Sayah
This work is licensed under a Creative Commons Attribution 4.0 International License.
